Abstract
Summary
Calcium supplements have been associated with increased cardiovascular risk, but the mechanism is unknown. We investigated the effects of calcium supplements on the propensity of serum to calcify, based on the transition time of primary to secondary calciprotein particles (T50). Changes in serum calcium were related to changes in T50.
Introduction
Calcium supplements have been associated with increased cardiovascular risk; however, it is unknown whether this is related to an increase in vascular calcification.
Methods
We investigated the acute and 3-month effects of calcium supplements on the propensity of serum to calcify, based on the transition time of primary to secondary calciprotein particles (T50), and on three possible regulators of calcification: fetuin-A, pyrophosphate and fibroblast growth factor-23 (FGF23). We randomized 41 postmenopausal women to 1 g/day of calcium as carbonate, or to a placebo containing no calcium. Measurements were performed at baseline and then 4 and 8 h after their first dose, and after 3 months of supplementation. Fetuin-A, pyrophosphate and FGF23 were measured in the first 10 participants allocated to calcium carbonate and placebo who completed the study.
Results
T50 declined in both groups, the changes tending to be greater in the calcium group. Pyrophosphate declined from baseline in the placebo group at 4 h and was different from the calcium group at this time point (p = 0.04). There were no other significant between-groups differences. The changes in serum total calcium from baseline were significantly related to changes in T50 at 4 h (r = −0.32, p = 0.05) and 8 h (r = −0.39, p = 0.01), to fetuin-A at 3 months (r = 0.57, p = 0.01) and to pyrophosphate at 4 h (r = 0.61, p = 0.02).
Conclusions
These correlative findings suggest that serum calcium concentrations modulate the propensity of serum to calcify (T50), and possibly produce counter-regulatory changes in pyrophosphate and fetuin-A. This provides a possible mechanism by which calcium supplements might influence vascular calcification.
Similar content being viewed by others
References
Bolland MJ, Grey A, Avenell A et al (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040
Bolland MJ, Avenell A, Baron JA et al (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691
Mao P-J, Zhang C, Tang L et al (2013) Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol 169:106–111
Lewis JR, Radavelli-Bagatini S, Rejnmark L et al (2015) The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res 30:165–175
Bolland MJ, Grey A, Avenell A et al (2015) Calcium supplements increase risk of myocardial infarction. J Bone Miner Res 30:389–390
Heaney RP, Dowell MS, Bierman J et al (2001) Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 20:239–246
Bristow SM, Gamble GD, Stewart A et al (2014) Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr 112:1611–1620
Rubin MR, Rundek T, McMahon DJ et al (2007) Carotid artery plaque thickness is associated with increased serum calcium levels: the northern Manhattan study. Atherosclerosis 194:426–432
Kwak SM, Kim JS, Choi Y et al (2014) Dietary intake of calcium and phosphorus and serum concentration in relation to the risk of coronary artery calcification in asymptomatic adults. Arterioscler Thromb Vasc Biol 34:1763–1769
Shin S, Kim KJ, Chang HJ et al (2012) Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J 33:2873–2881
Bolland MJ, Wang TK, van Pelt NC et al (2010) Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction. J Bone Miner Res 25:505–512
Russo D, Miranda I, Ruocco C et al (2007) The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 72:1255–1261
Li S, Na L, Li Y et al (2013) Long-term calcium supplementation may have adverse effects on serum cholesterol and carotid intima-media thickness in postmenopausal women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 98:1353–1359
Heiss A, DuChesne A, Denecke B et al (2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278:13333–13341
Meyer JL (1984) Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231:1–8
Moe OW, Kuro-o M (2014) Fibroblast growth factor 23 and uremic vascular calcification: is it time to escalate from biomarker status to pathogenic agent? Kidney Int 85:1022–1023
Reid IR, Bolland MJ, Grey A (2010) Does calcium supplementation increase cardiovascular risk? Clin Endocrinol 73:689–695
Pasch A, Farese S, Graber S et al (2012) Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23:1744–1752
Keyzer CA, de Borst MH, van den Berg E et al (2015) Calcification propensity and survival among renal transplant recipients. J Am Soc Nephrol
Smith ER, Ford ML, Tomlinson LA et al (2014) Serum calcification propensity predicts all-cause mortality in pre-dialysis CKD. J Am Soc Nephrol 25:339–348
Lomashvili KA, Khawandi W, O'Neill WC (2005) Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16:2495–2500
Schaible J, Wigger M, Staude H et al (2012) Serum fetuin-A and vitamin D in children with mild-to-severe chronic kidney disease: a cross-sectional study. Nephrol Dial Transplant 27:1107–1113
Liang J, Wang Z, Liu G et al (2014) Association of dialysate calcium concentration with fetuin a level and carotid intima-media thickness in peritoneal dialysis patients. Ren Fail 36:65–68
Mehrotra R, Westenfeld R, Christenson P et al (2005) Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 67:1070–1077
Hamano T, Matsui I, Mikami S et al (2010) Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21:1998–2007
O'Neill WC, Sigrist MK, McIntyre CW (2010) Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol Dial Transplant 25:187–191
Wesseling-Perry K, Wang H, Elashoff R et al (2014) Lack of FGF23 response to acute changes in serum calcium and PTH in humans. J Clin Endocrinol Metab 99:E1951–E1956
Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR et al (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190–1197
Kobayashi K, Imanishi Y, Miyauchi A et al (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93–99
Imanishi Y, Inaba M, Nakatsuka K et al (2004) FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65:1943–1946
Nishida Y, Taketani Y, Yamanaka-Okumura H et al (2006) Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70:2141–2147
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by a government ethics committee and all participants gave informed consent.
Conflicts of interest
Andreas Pasch is a co-founder of Calciscon AG, Bern, Switzerland. Sarah Bristow, Greg Gamble, W. Charles O’Neill, Angela Stewart, Anne Horne and Ian Reid have no disclosures to declare.
Additional information
This paper was supported by the Health Research Council of New Zealand.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 156 kb)
Rights and permissions
About this article
Cite this article
Bristow, S.M., Gamble, G.D., Pasch, A. et al. Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial. Osteoporos Int 27, 1209–1216 (2016). https://doi.org/10.1007/s00198-015-3372-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-015-3372-y